Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MLTX | AMGN | VRTX | GILD | BMY |
| Company | Moonlake Immunotherapeutics | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 50.46 | 322.48 | 507.17 | 96.05 | 54.70 |
| High | 52.00 | 328.25 | 519.88 | 97.32 | 54.79 |
| Low | 50.02 | 321.28 | 504.94 | 94.91 | 53.97 |
| Last | 51.78 | 325.28 | 516.74 | 96.57 | 54.14 |
| Change | +1.11 | +3.37 | +14.29 | -1.33 | -0.57 |
| % Change | +2.19% | +1.05% | +2.84% | -1.36% | -1.04% |
| Volume | 195,000 | 1,978,100 | 1,259,400 | 7,457,000 | 9,218,631 |
| 20-Day Average Volume | 221,505 | 1,854,090 | 1,116,445 | 5,992,175 | 9,204,140 |
| Previous Close | 50.67 | 321.91 | 502.45 | 97.90 | 54.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 48.20 | 319.58 | 483.26 | 89.04 | 53.57 |
| 20-Day Raw Stochastic | 92.11% | 83.14% | 94.47% | 87.48% | 51.55% |
| 20-Day Relative Strength | 57.10% | 54.16% | 64.99% | 76.26% | 55.99% |
| Weighted Alpha | +31.42 | +19.80 | +38.80 | +40.05 | +13.03 |
| Today's Opinion | 64% Buy | 40% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 64% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 32% Buy | 40% Buy | 40% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.74% since 11/01/24 | +1.90% since 11/01/24 | +9.68% since 11/01/24 | +7.89% since 11/01/24 | -0.33% since 11/01/24 |
| Low | 45.27 on 11/04/24 | 313.02 on 11/05/24 | 468.77 on 11/04/24 | 89.01 on 11/05/24 | 53.97 on 11/08/24 |
| High | 52.34 on 11/07/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 1-Month | |||||
| %Chg | +3.87% since 10/08/24 | +2.39% since 10/08/24 | +12.59% since 10/08/24 | +13.33% since 10/08/24 | +3.16% since 10/08/24 |
| Low | 45.24 on 10/31/24 | 310.63 on 10/30/24 | 456.16 on 10/09/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 52.34 on 11/07/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 3-Month | |||||
| %Chg | +12.44% since 08/08/24 | +0.18% since 08/08/24 | +10.90% since 08/08/24 | +27.75% since 08/08/24 | +15.56% since 08/08/24 |
| Low | 43.44 on 08/09/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.48 on 08/12/24 |
| High | 56.00 on 10/07/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 6-Month | |||||
| %Chg | +21.46% since 05/08/24 | +5.85% since 05/08/24 | +23.38% since 05/08/24 | +48.75% since 05/08/24 | +23.98% since 05/08/24 |
| Low | 37.55 on 06/24/24 | 295.30 on 06/13/24 | 416.03 on 05/09/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 56.00 on 10/07/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,237,002 | 173,037,264 | 129,395,448 | 121,884,712 | 110,961,560 |
| Shares Outstanding, K | 63,884 | 537,533 | 257,529 | 1,244,992 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -36,010,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,645,600,000 | 6,954,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -24,270,000 | 2,830,000,000 | -3,593,600,000 | 1,614,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.28 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.56 on 11/07/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.74 | 0.00 | 20.70 | 47.25 |